Market Tracker

03/04 6:00am ET

Actavis PLC (NYSE:ACT)

296.23
Delayed Data
As of Mar 03
 -1.08 / -0.36%
Today’s Change
184.71
Today|||52-Week Range
297.50
+15.08%
Year-to-Date

Today’s Trading

Previous close297.31
Today’s open296.80
Day’s range-- - --
Volume2,926,876
Average volume (3 months)2,829,325
Market cap$83.1B
Dividend yield--
Data as of 03/03/2015

Growth & Valuation

Earnings growth (last year)-40.80%
Earnings growth (this year)+22.53%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+50.53%
P/E ratioNM
Price/Sales4.33
Price/Book--

Competitors

 Today’s
change
Today’s
% change
AZNAstraZeneca-0.45-0.65%
LLYEli Lilly and Co-0.75-1.05%
ABTAbbott Laboratories-0.13-0.28%
AGNAllergan-0.94-0.40%
Data as of 03/03/2015

Financials

Next reporting dateApril 29, 2015
EPS forecast (this quarter)$4.08
Annual revenue (last year)$13.1B
Annual profit (last year)-$1.6B
Net profit margin-12.48%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Brenton L. Saunders
Chief Operating Officer
Robert A. Stewart
Corporate headquarters
Dublin, Dublin

Forecasts